Prototypes of newly conceived inorganic and biological sensors for health and environmental applications

Sensors (Switzerland)

Volumn 12, Issue 12, 2012, Pages 17112-17127

  Nicolini, Claudio ^a,b   Adami, Manuela ^c   Sartore, Marco ^c   Bragazzi, Nicola Luigi ^a   Bavastrello, Valter ^a   Spera, Rosanna ^a   Pechkova, Eugenia ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Nanoworld Institute Fondazione ELBA Nicolini   (Italy)

^c Elbatech srl   (Italy)

Author keywords

Amperometry; Calcium oxide matrices; Clomipramine; CO2; Laccase; Langmuir Blodgett; Protein protein interaction; QCM_D

Indexed keywords

AMPEROMETRY; CLOMIPRAMINE; LACCASES; LANGMUIR-BLODGETT; OXIDE MATRIX; PROTEIN-PROTEIN INTERACTIONS; QCM_D;

BIOSENSORS; CARBON DIOXIDE; ENZYMES; LIME; PROTEINS;

DIAGNOSIS;

CALCIUM DERIVATIVE; CALCIUM OXIDE; CARBON DIOXIDE; LACCASE; NANOCOMPOSITE; OXIDE;

ARTICLE; CHEMISTRY; ENVIRONMENTAL MONITORING; GENETIC PROCEDURES; HUMAN; ISOLATION AND PURIFICATION; NANOTECHNOLOGY; QUARTZ CRYSTAL MICROBALANCE;

BIOSENSING TECHNIQUES; CALCIUM COMPOUNDS; CARBON DIOXIDE; ENVIRONMENTAL MONITORING; HUMANS; LACCASE; NANOCOMPOSITES; NANOTECHNOLOGY; OXIDES; QUARTZ CRYSTAL MICROBALANCE TECHNIQUES;

EID: 84871681342     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s121217112     Document Type: Article

References (33)

1. Nicolini, C.; Sivozhelezov, V.; Bavastrello, V.; Bezzerra, T.; Scudieri, D.; Spera, R.; Pechkova, E. Matrices for sensors from inorganic, organic, and biological nanocomposites. Materials 2011, 4, 1483-1518.
2. Bezerra, T.C.T.; Bavastrello, V.; Nicolini, C. Calcium oxide matrices and carbon dioxide sensors. Sensors 2012, 12, 5896-5905.
3. Nicolini, C.; Bragazzi, N.; Pechkova, E. Nanoproteomics enabling personalized nanomedicine. Adv. Drug Deliv. Rev. 2012, 64, 1522-1531.
4. Adami, M.; Sallam, S.; Eggenhoffner, R.; Sartore, M.; Hainsworth, E.; LaBaer, J.; Nicolini, C. Label-free NAPPA via Nanogravimetry, in Functional Proteomics and Nanotechnology-Based Microarrays. In Pan Stanford Series on Nanobiotechnology; Nicolini, C., LaBaer, J., Eds.; Pan Stanford Publishing Pte Ltd.: Singapore, 2010; Volume 2, Chapter 4, pp. 95-108.
5. Bragazzi, N.L.; Pechkova, E.; Scudieri, D.; Bezerra, T.C.T.; Adami, M.; Nicolini, C. Recombinant laccase: II. Medical biosensor. Crit. Rev. Eukaryot. Gene. Expr. 2012, 22, 197-203.
6. Nicolini, C.; Bruzzese, D.; Cambria, M.T.; Bragazzi, N.L.; Pechkova, E. Recombinant laccase: I. Enzyme cloning and characterization. J. Cell Biochem. 2012, doi:10.1002/jcb.24397.
7. Nicolini, C.; Adami, M.; Dubrovsky, T.; Erokhin, V.; Facci, P.; Paschkevitch, P.; Sartore, M. High sensitivity biosensor based on LB technology and on nanogravimetry. Sens. Actuators B Chem. 1995, 24, 121-128.
8. Pax, M.; Rieger, J.; Eibl, R.H.; Thielemann, C.; Johannsmann, D. Measurements of fast fluctuations of viscoelastic properties with the quartz crystal microbalance. Analyst 2005, 130, 1474-1477.
9. Poitras, C.; Tufenkji, N. A QCM_D-based biosensor for E. coli O157:H7 highlighting the relevance of the dissipation slope as a transduction signal. Biosens. Bioelectron. 2009, 24, 2137-2142.
10. Ramachandran, N.; Hainsworth, E.; Bhullar, B.; Eisenstein, S.; Rosen, B.; Lau, A.Y.; Walter, J.C.; LaBaer, J. Self-Assembling protein microarrays. Science 2004, 305, 86-90.
11. Nicolini, C.; Pechkova, E. An overview of nanotechnology-based functional proteomics for cancer and cell cycle progression. Anticancer Res. 2010, 30, 2073-2080.
12. Nicolini, C.; Bezerra, T.; Pechkova, E. Protein nanotechnology for new design and development of biocrystals and biosensors. Nanomedicine (Lond.) 2012, 78, 1117-1120.
13. Efeyan, A.; Serrano, M. p53: Guardian of the Genome and Policeman of the Oncogenes. Cell Cycle 2007, 6, 1006-1010.
14. Levine, A.J. P53, the cellular gatekeeper for growth and division. Cell 1997, 88, 323-331.
15. Vousden, K.H.; Lu, X. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2002, 2, 594-604.
16. Shangary, S.; Wang, S. Targeting the MDM2-p53 Interaction for cancer therapy. Clin. Cancer Res. 2008, 14, 5318-5324.
17. Spera, R.; LaBaer, J.; Nicolini, C. Mass spectrometry detection of nucleic acid programmable protein array. J. Mass. Spectrom. 2011, 46, 960-965.
18. Shumantseva, V.; De Luca, G.; Bulko, T.; Carrara, S.; Nicolini, C.; Usanov, S.A.; Archakov, A. Cholesterol amperometric biosensor based on cytochrome P450scc. Biosens. Bioelectron. 2004, 19, 971-976.
19. Stura, E.; Bruzzese, D.; Valerio, F.; Grasso, V.; Perlo, P.; Nicolini, C. Anodic porous alumina as mechanical stability enhancer for LDL-cholesterol sensitive electrodes. Biosens. Bioelectron. 2007, 23, 655-660.
20. Nicolini, C.; Pechkova, E. Nanostructured biofilms and biocrystals. J. Nanosci. Nanotechnol. 2006, 6, 2209-2236.
21. Danish University Antidepressant Group (DUAG). Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Clin. Pharmacol. Ther. 1999, 66, 152-165.
22. Goodman-Gilman, A. The Pharmacological Basis of Therapeutics, 7th eds.; Macmillan: New York, NY, USA, 1985; Chapter 17, p. 431.
23. Baumann, P.; Hiemke, C.; Ulrich, S.; Eckermann, G.; Gaertner, I.; Gerlach, M.; Kuss, H.; Laux, G.; Mueller Oerlinghausen, B.; Rao, M.L.; et al. The AGNP-TDM Expert Group Consensus Guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004, 37, 243-265.
24. Stage, K.B.; Bech, P.; Kragh-Sørensen, P. Age-related adverse reactions to Clomipramine. Acta Psychiat. Scand. 2002, 105, 55-59.
25. Nalin, D.R. Evidence based vaccinology. Vaccine 2002, 20, 11-12.
26. Nicolini, C.; Pechkova, E. Nanoproteomics for nanomedicine. Nanomedicine 2010, 5, 677-682.
27. Moreno, N.; Chevalier, M.; Ronzon, F.; Manin, C.; Dupuy, M.; Krell, T.; Rieu, J.P. Unbinding forces of single pertussis toxin-antibody complexes measured by atomic force spectroscopy correlate with their dissociation rates determined by surface plasmon resonance. J. Mol. Recognit. 2011, 6, 1105-1114.
28. Mandenius, C.F.; Wang, R.; Aldén, A.; Bergström, G.; Thébault, S.; Lutsch, C.; Ohlson, S. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance. Anal. Chim. Acta 2008, 623, 66-75.
29. Schimmell, M.S.; Katz, E.Z.; Shaag, Y.; Pastuszak, A.; Koren, G. Toxic neonatal effects following maternal clomipramine therapy. J. Toxicol. Clin. Toxicol. 1991, 29, 479-484.
30. Kohen, D. Psychotropic medication and breast-feeding. Adv. Psychiatr. Treat. 2005 11, 371-379.
31. Melanson, S.E.; Lewandrowski, E.L.; Griggs, D.A.; Flood, J.G. Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis. J. Anal. Toxicol. 2007, 31, 270-275.
32. Altemus, M.; Swedo, S.E.; Leonard, H.L.; Richter, D.; Rubinow, D.R.; Potter, W.Z.; Rapoport, J.L. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch. Gen. Psychiatry 1994, 51, 794-803.
33. Mårtensson, B.; Wägner, A.; Beck, O.; Brodin, K.; Montero, D.; Asberg, M. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatr. Scand. 1991, 83, 125-133.